Polarean Imaging (GB:POLX) has released an update.
Polarean Imaging plc has announced a trade-in agreement with the University of Kansas Medical Center to upgrade their MRI technology with Polarean’s latest FDA-approved clinical-grade Xenon MRI system. The new system will enhance research across multiple lung diseases and is expected to be installed later this year, aiding in clinical imaging and various studies including NIH-funded and pharmaceutical-sponsored trials. This upgrade signifies the increasing significance of Xenon MRI technology in pulmonary diagnostics and treatment monitoring.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
